Lipika Goyal

Also affiliated with Stanford University

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 27 papers. Top paper: “Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers”.

Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers

Journal of Clinical Investigation(2021)10.1172/jci152670

N/A

2.1DataRank · unranked

86 citations

Leslie Cope, Amanda N. Ruggieri, Robert A. Anders, Anne M. Noonan, Laura W. Goff +24 more

Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare Network

The Oncologist(2022)10.1093/oncolo/oyac134

N/A

0.867DataRank · unranked

22 citations

Rebecca S. Heist, Adam Z. Bard, Annacarolina F L da Silva, Ibiayi Dagogo‐Jack, Valentina Nardi +45 more

Immunology and immunotherapy of cholangiocarcinoma

Nature Reviews Gastroenterology & Hepatology(2023)10.1038/s41575-022-00741-4

N/A

0.787DataRank · unranked

189 citations

Robert F. Schwabe, Nabeel Bardeesy, Lichun Ma, Lipika Goyal, Robin Kate Kelley +2 more

Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001435

N/A

0.754DataRank · unranked

151 citations

Aya Matsui, Hiroto Kikuchi, Sebastian Klein, Émilie Mamessier, Ivy X. Chen +21 more

FGFR mRNA Expression in Cholangiocarcinoma and Its Correlation with FGFR2 Fusion Status and Immune Signatures

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1244

N/A

0.748DataRank · unranked

15 citations

Azfar Neyaz, Abhijit Chogule, Islam Baiev, Stephanie Reyes, Emily G. Barr Fritcher +7 more

FGFR2 Extracellular Domain In-Frame Deletions Are Therapeutically Targetable Genomic Alterations That Function as Oncogenic Drivers in Cholangiocarcinoma

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1669

N/A

0.705DataRank · unranked

109 citations

Srivatsan Raghavan, Qibiao Wu, Yvonne Y. Li, Liam F. Spurr, Hersh Gupta +35 more

Pemigatinib in previously treated solid tumors with activating FGFR1–FGFR3 alterations: phase 2 FIGHT-207 basket trial

Nature Medicine(2024)10.1038/s41591-024-02934-7

N/A

0.637DataRank · unranked

69 citations

Silvia Damian, Muhammad Furqan, Jesús García-Donás, Hiroo Imai, Antoîne Italiano +10 more

O-2 Phase III study of NUC-1031 + cisplatin vs gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121)

Annals of Oncology(2023)10.1016/j.annonc.2023.04.017

N/A

0.624DataRank · unranked

5 citations

I. Bazin, Do‐Youn Oh, O. Zubkov, V. Breder, Li‐Yuan Bai +16 more

Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer

Cancer Discovery(2022)10.1158/2159-8290.cd-21-1117

N/A

0.617DataRank · unranked

60 citations

Aparna R. Parikh, Alexander Solovyov, Eunae You, Anupriya S. Kulkarni, Chong Chu +44 more

Tumor biology and immune infiltration define primary liver cancer subsets linked to overall survival after immunotherapy

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101052

N/A

0.520DataRank · unranked

31 citations

Erica C. Pehrsson, Aiwu Ruth He, Lipika Goyal, Robin Kate Kelley, Hien Dang +26 more

Obesity/Type 2 Diabetes-Associated Liver Tumors Are Sensitive to Cyclin D1 Deficiency

Cancer Research(2020)10.1158/0008-5472.can-20-0106

N/A

0.464DataRank · unranked

21 citations

Jiaxin Liang, Kfir Sharabi, Maximilian Hatting, Elizabeth A. Perry, Clint D.J. Tavares +7 more

Phase Ib and Expansion Study of Gemcitabine,Nab-Paclitaxel, and Ficlatuzumab in Patients With Metastatic Pancreatic Cancer

The Oncologist(2023)10.1093/oncolo/oyad002

N/A

0.369DataRank · unranked

7 citations

Anna M. Chiarella, James M. Cleary, Nora Horick, Colin D. Weekes, Thomas A. Abrams +21 more

Characterization of cell states in biliary tract cancers identifies mechanisms of therapeutic resistance in a phase II trial of DKN-01/nivolumab

medRxiv(2024)10.1101/2024.10.08.24315092

N/A

0.208DataRank · unranked

3 citations

Milan Parikh, Leon Pappas, Moshe Sade-Feldman, Anupriya S. Kulkarni, Lynn Bi +19 more

Data from Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer

(2023)10.1158/1078-0432.c.6530634

N/A

0DataRank · unranked

0 citations

Emily E. Van Seventer, Giulia Siravegna, Anna Hartwig, Ariel Jaimovich, Yupeng He +38 more

Data from Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer

(2023)10.1158/1078-0432.c.6530634.v1

N/A

0DataRank · unranked

0 citations

Emily E. Van Seventer, Giulia Siravegna, Anna Hartwig, Ariel Jaimovich, Yupeng He +38 more

Data from FGFR mRNA Expression in Cholangiocarcinoma and Its Correlation with FGFR2 Fusion Status and Immune Signatures

(2023)10.1158/1078-0432.c.6532707.v1

N/A

0DataRank · unranked

0 citations

Azfar Neyaz, Abhijit Chogule, Islam Baiev, Stephanie Reyes, Emily G. Barr Fritcher +7 more

Data from FGFR mRNA Expression in Cholangiocarcinoma and Its Correlation with FGFR2 Fusion Status and Immune Signatures

(2023)10.1158/1078-0432.c.6532707

N/A

0DataRank · unranked

0 citations

Azfar Neyaz, Abhijit Chogule, Islam Baiev, Stephanie Reyes, Emily G. Barr Fritcher +7 more

Data from Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer

(2023)10.1158/2159-8290.c.6549619.v1

N/A

0DataRank · unranked

0 citations

Aparna R. Parikh, Alexander Solovyov, Eunae You, Anupriya S. Kulkarni, Chong Nam Chu +44 more

Data from RLY-4008, the First Highly Selective FGFR2 Inhibitor with Activity across FGFR2 Alterations and Resistance Mutations

(2023)10.1158/2159-8290.c.6749764.v1

N/A

0DataRank · unranked

0 citations

Vaibhav Sahai, Dejan Maglic, Kamil Bruderek, B. Barry Touré, Songping Zhao +26 more

Determining the time to cholangiocarcinoma in pediatric‐onset PSC‐IBD

Journal of Pediatric Gastroenterology and Nutrition(2024)10.1002/jpn3.12443

N/A

0DataRank · unranked

3 citations

Johan Fevery, Douglas G. Adler, Annika Bergquist, Lissy de Ridder, Mark Deneau +10 more

EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion–Positive Cholangiocarcinoma

Cancer Discovery(2022)10.1158/2159-8290.cd-21-1168

N/A

0DataRank · unranked

99 citations

Yuanli Zhen, Lei Shi, Phuong Vu, Patricia Greninger, Ramzi Adil +18 more

Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3467

N/A

0DataRank · unranked

143 citations

Amikasra Mojtahed, Jaime L. Schneider, Katie Kanter, Emily E. Van Seventer, Isobel J. Fetter +25 more

How I treat biliary tract cancer

ESMO Open(2022)10.1016/j.esmoop.2021.100378

N/A

0DataRank · unranked

136 citations

Julien Edeline, Lipika Goyal, Ángela Lamarca

Paving a pathway for drug development in HER2-positive biliary tract cancer

The Lancet Oncology(2021)10.1016/s1470-2045(21)00465-4

N/A

0DataRank · unranked

0 citations

Lipika Goyal, Christopher T. Chen

Cholangiocarcinoma — novel biological insights and therapeutic strategies

Nature Reviews Clinical Oncology(2023)10.1038/s41571-023-00770-1

N/A

0DataRank · unranked

206 citations

Silvia Affò, Lipika Goyal, Ángela Lamarca, Gonzalo Sapisochín, Ju Dong Yang +2 more

Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad046

N/A

0DataRank · unranked

28 citations

Leontios Pappas, Islam Baiev, Jordan R. Maurer, Andrea Grace Bocobo, Karen Zhang +25 more

Resection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC): Clinical Features and Outcomes Compared with HCC Due to Other Etiologies

The Oncologist(2023)10.1093/oncolo/oyac251

N/A

0DataRank · unranked

22 citations

Stephanie Reyes, Matthew Chase, Aparna Govindan, Lei Zhao, Jay Luther +26 more